Merck scores FDA approval for subcutaneous Keytruda, securing potential blockbuster protection
19th September 2025 Uncategorised 0The FDA has approved Merck & Co.’s under-the-skin version of Keytruda, reducing treatment time burden for patients while granting the world’s best-selling drug potential blockbuster revenue protection.
More: Merck scores FDA approval for subcutaneous Keytruda, securing potential blockbuster protection
Source: fierce